Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
about
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
@en
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
@nl
type
label
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
@en
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
@nl
prefLabel
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
@en
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
@nl
P2093
P2860
P356
P1433
P1476
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells.
@en
P2093
P2860
P304
26605-26615
P356
10.18632/ONCOTARGET.24902
P407
P577
2018-06-01T00:00:00Z